Cargando…
Multidrug-resistance proteins are weak tumor associated antigens for colorectal carcinoma
BACKGROUND: Multidrug resistance (MDR) is a clinically, highly relevant phenomenon. Under chemotherapy many tumors show an increasing resistance towards the applied substance(s) and to a certain extent also towards other agents. An important molecular cause of this phenomenon is an increased express...
Autores principales: | Mullins, Christina S, Eisold, Sven, Klar, Ernst, Linnebacher, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160416/ https://www.ncbi.nlm.nih.gov/pubmed/21740599 http://dx.doi.org/10.1186/1471-2172-12-38 |
Ejemplares similares
-
Tumor Take Rate Optimization for Colorectal Carcinoma Patient-Derived Xenograft Models
por: Gock, Michael, et al.
Publicado: (2016) -
Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens
por: Wagner, Sandra, et al.
Publicado: (2018) -
Optimizing the process of nucleofection for professional antigen presenting cells
por: Mullins, Christina Susanne, et al.
Publicado: (2015) -
Integrated Biobanking and Tumor Model Establishment of Human Colorectal Carcinoma Provides Excellent Tools for Preclinical Research
por: Mullins, Christina S., et al.
Publicado: (2019) -
Murine Endogenous Retroviruses Are Detectable in Patient-Derived Xenografts but Not in Patient-Individual Cell Lines of Human Colorectal Cancer
por: Bock, Stephanie, et al.
Publicado: (2018)